Stock Research: Quest Diagnostics

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Quest Diagnostics

NYSE:DGX US74834L1008
65
  • Value
    46
  • Growth
    37
  • Safety
    Safety
    55
  • Combined
    34
  • Sentiment
    91
  • 360° View
    360° View
    65
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Quest Diagnostics Incorporated is a provider of diagnostic information services, offering insights from laboratory testing to improve health outcomes. It operates in the diagnostic information services industry, primarily under the Quest Diagnostics brand, and also includes AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum. The company provides broad access to clinical testing through a nationwide network of laboratories and patient service centers, indicating operations primarily in the United States. In the last fiscal year, the company had 45000 employees, a market capitalization of $18578 million, profits of $3273 million, and revenue of $9872 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 65 (better than 65% compared with alternatives), overall professional sentiment and financial characteristics for the stock Quest Diagnostics are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Quest Diagnostics. The consolidated Value Rank has an attractive rank of 55, which means that the share price of Quest Diagnostics is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 55% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 91, which means that professional investors are more optimistic about the stock than for 91% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 37, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 46, meaning the company has a riskier financing structure than 54 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
Dividends USA
Diversity USA
D.J. US Health Care
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 59 76 83
Growth
37 52 7 37
Safety
Safety
46 11 54 58
Sentiment
91 83 37 89
360° View
360° View
65 45 30 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
42 52 28 40
Opinions Change
94 43 25 55
Pro Holdings
n/a 100 55 95
Market Pulse
88 94 71 78
Sentiment
91 83 37 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
55 59 76 83
Growth
37 52 7 37
Safety Safety
46 11 54 58
Combined
34 18 35 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
46 44 61 54
Price vs. Earnings (P/E)
20 16 20 34
Price vs. Book (P/B)
30 38 50 71
Dividend Yield
88 93 94 92
Value
55 59 76 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
18 29 12 5
Profit Growth
52 54 27 66
Capital Growth
23 42 28 33
Stock Returns
75 75 23 71
Growth
37 52 7 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
35 36 46 52
Refinancing
28 19 27 37
Liquidity
67 26 71 71
Safety Safety
46 11 54 58

Similar Stocks

Discover high‑ranked alternatives to Quest Diagnostics and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.